AI Proteins

About AI Proteins

AI Proteins is focused on designing a new class of de novo miniprotein medicines. Their vision is to build flawless medicines from first principles using AI, with a next-generation modality that emphasizes speed, scale, precision, and safety. These biologics are potent, programmable, and engineered for specific treatment needs.

Products & Services

Miniprotein Medicines:A next-generation modality of biologics designed by AI, validated in the lab, and built for speed, scale, and precision. They are potent, programmable, safe, and engineered for specific, predictable purposes with enhanced tissue penetration and low immunogenicity.

Platform:A platform for designing and exploring miniproteins, supporting high-throughput exploration of combinatorial spaces free from human bias.

Pipeline:A pipeline of miniprotein-based treatments under development, focused on controllable pharmacokinetics and patient-specific needs.

Specialties

AI-driven protein design Miniprotein medicines Biologics development Precision medicine

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 41500000 MR: - FA: 41.5 million FAN: 41500000	D: 2025-11-19 FD: 2025-11-19	4 investors

Series A Latest

2025-11-19

$41.5M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chris Bahl

President, Chief Executive Officer, Founder

LinkedIn (Pro only)

A

Aislynn Fontaine

Research Associate

A

Alyssa Anderson

Investigator, Head of Protein Characterization

A

Arturo Vera Rodriguez

Senior Investigator, Head of Bioprocess Development

B

Ben Meinen

Investigator, Head of Protein Design

C

Collin McKenna

Scientist

View 34 more team members with Pro

Unlock Full Team Directory

Recent News

AI Proteins Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised